Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Market indices provide a snapshot of broad performance and risk. This overview outlines why investors rely on them for benchmarking.
28,391 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
U.S. lawmakers pledge rigorous oversight as the DOJ expands its probe into Binance’s sanctions compliance. The move s...
Snowflake closes its first full year under new CEO Sridhar Ramaswamy with solid revenue gains and a bold AI strategy,...
A niche gold strategy that pairs silver-like cash flow with gold exposure is gaining traction. IAUI offers about 12% ...
Bitcoin surged past $70,000 on signs that U.S. actions against Iran would be paused for five days, sparking a broad r...
A senior U.S. senator warns that college grad unemployment will surge as AI reshapes entry-level work, potentially up...
North Korea’s Foreign Ministry rejected cyber theft accusations as 'absurd slander,' arguing the claims are political...
If Spirit faces liquidation, the fleet faces a multi-step journey from repossession to resale. Here's a concise brief...
Saudi Aramco posted a 25% year-over-year profit rise in Q1, supported by higher crude prices and rerouted exports ami...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Valr confirms a Kenya-focused expansion as regulators finalize digital asset rules and Kenya’s fintech scene accelera...
A November-like standoff erupts as MRED suspends Zillow’s access to Chicagoland listing data, potentially reshaping h...